April 25 (Reuters) - Bausch Health Companies Inc BHC.TO :
* SALIX ENTERS INTO EXCLUSIVE LICENSE AGREEMENT WITH MITSUBISHI TANABE PHARMA TO DEVELOP AND COMMERCIALIZE LATE STAGE INVESTIGATIONAL S1P MODULATOR FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
* SALIX PHARMACEUTICALS - AFFILIATE HAS ENTERED INTO AN EXCLUSIVE LICENSING AGREEMENT WITH MITSUBISHI TANABE PHARMA TO DEVELOP AND COMMERCIALIZE MT-1303